With or Without Residual C-Peptide, Patients with Type 2 Diabetes Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring

Diabetes Technology&Therapeutics, Ahead of Print.

Source: Diabetes Technology and Therapeutics - March 21, 2022 Category: Endocrinology Authors: Ryan Bailey Peter Calhoun Christy Chao Tomas C. Walker Source Type: research